Key Takeaways
- Growth paused by self-inflicted expansion: Revenue grew 10% YoY but fell sequentially because Changodar's modernization and expansion choked utilization to 27%, a temporary project drag, not a demand signal.
- The order book is the real story: An ultra-mega PGCIL order above INR1,000 crores plus GETCO, RRVPNL and a US export win landed in the quarter, keeping the order inflow growth rate at 30%.
- Backward integration is the margin unlock, but it is a FY28 story: CTC, pressboard, bushing and fabrication plants commission through FY27; the 200-300 bps margin benefit starts only in FY28, while depreciation hits at the same time.
- Inventory is a deliberate geopolitical hedge, not a leak: Raw material stocked through December 2026 to bridge the gap until backward integration goes live; management calls it protection, and it will unwind from Q4 FY28.
- What to watch next quarter: Whether Changodar utilization begins its promised climb from August 2026, the pace of Moraiya's recovery from 57%, and any update on the HVDC trial-order timeline with PGCIL.
The Changodar Drag: Expansion Eating Its Own Output
- Utilization collapsed to 27%: The facility is undergoing capacity expansion, product-line-specific engineering modifications and testing-infrastructure upgrades, all of which directly reduced operational throughput in Q1. Management calls this purely project-related and temporary.
- Monsoon added to the delays: Extreme weather impacted construction timelines and labour availability, pushing the completion target to August 2026. After that, utilization is expected to improve progressively, though this year it will still only reach 60-65%.
- Moraiya also underperformed: Utilization at 57-65% was attributed to geopolitical issues in the past quarter that have since been addressed; raw material is now protected until December. Management expects a pretty good improvement this quarter and 80-85% is not far-fetched going forward.
- No more capacity being added: The immediate priority is maximizing utilization, improving throughput and enhancing operational efficiency across all existing facilities, not building new transformer manufacturing lines.
Satyen Mamtora: "So looking at the geopolitical situation, we have protected ourselves until December, and we are pretty much sure that all our backward integration plants will be ready by December."
Order Book & Demand Visibility
- The PGCIL order changes the scale: An ultra-mega order above INR1,000 crores for transformers of various ratings, to be executed within 30 months, anchors the book and validates the company's technical credentials alongside the quarter's successful dynamic short-circuit testing of four units.
- Export and domestic wins broadened the base: GETCO (INR228 crores), RRVPNL (INR175 crores) and a US export order from PDC AK LPIV (INR150 crores) all landed in Q1. Management is maintaining a 30% order inflow growth rate across both domestic and export markets for FY27.
- Revenue target revised for FX, not ambition: The earlier \$1 billion target now translates to INR8,000 crores by FY29 due to rupee depreciation; FY29 looks very achievable per management, with a clear FY28 guideline promised in Q4.
Backward Integration: The Margin Thesis, Delayed
| Facility | Commissioning Timeline |
|---|---|
| CRGO processing | Already operational |
| CTC plant | Q2 FY27 |
| Pressboard and insulation | Q3 FY27 |
| RIP bushings | Q4 FY27 |
| Fabrication facility | Q1 FY28 |
- The prize is 80-85% in-house raw material: Once all facilities are running, the company expects to cover the bulk of its component requirement internally, which management frames as a significant competitive advantage in an industry where component availability remains a global bottleneck.
- The margin benefit is real but back-end loaded: 200 to 300 basis points of margin expansion is expected, but it begins gradually only from FY28, and depreciation will hit in the same year once capitalization occurs. The FY27 margin target remains 16% EBITDA.
- Inventory is the bridge to that future: High inventory levels reflect raw material procured through December 2026 to cover requirements until backward integration is operational. This is temporary and will reduce gradually starting Q4 FY28.
Satyen Mamtora: "In transformer industry, where component availability remains a key bottleneck globally, we believe backward integration will become a significant competitive advantage for TARIL over the coming years."
Margins: Consolidated Strength, Standalone Pressure
- Standalone EBITDA margin at 15.6%: The lower utilization at Changodar weighed on the standalone entity, while consolidated EBITDA margin was healthier at 19.2%, reflecting the benefit of integrated operations and subsidiary contributions.
- Employee cost halved QoQ: The drop from INR38 crores to INR22 crores was driven by the absence of last quarter's provisions for ESOP and MD commission, not an underlying cost reduction.
- Other expenses stable: At ~INR66 crores versus INR69.74 crores last year, with no one-off items or major reductions cited.
- Consolidated margin outlook: Margins will be higher than FY26 for the consolidated company, supported by improving utilization and the gradual backward integration ramp.
HVDC & Technology Bets
- HVDC is 15-16 months from manufacturing readiness: Nine months remain to complete repair work on the HVDC facility, after which PGCIL will empanel the company for a first trial order. The design strategy is hybrid, but management declined to elaborate, citing manufacturing secrecy.
- Dynamic short-circuit testing passed: Four transformer units successfully withstood extreme electrical and mechanical stresses under fault conditions per stringent international standards, a technical validation that supports the company's bid credentials for complex orders.
Satyen Mamtora: "We are looking at hybrid. These are basically not patented, but manufacturing secrecy kind of thing. So we would not like to discuss any further on this, but it will be based on hybrid systems."
Balance Sheet & Funding
- Capex plan is funded without fresh debt: The Changodar expansion (INR150 crores) and backward integration (INR900-1,000 crores) will be financed through a disciplined mix of QIP proceeds, leasing arrangements, internal accruals and debt only if required. Management explicitly stated it will not like to increase debt.
- Working capital target of 120-130 days: The cycle will be squeezed to generate additional capital, and receivables have already reduced as of June 2026 with certain realizations coming in April.
- Receivables improvement: Levels reduced as of 30 June 2026, with certain receivables realized in April.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Revenue growth | 25% in FY27; 30% across all sectors this year | FY27 |
| EBITDA margin | 16% standalone | FY27 |
| PAT margin | 9% to 10% | FY27 |
| Changodar expansion completion | Utilization to improve progressively thereafter; 60-65% this year, 80-85% next year | August 2026 |
| CTC facility commissioning | Backward integration step one | Q2 FY27 |
| Pressboard and insulation facility | Backward integration step two | Q3 FY27 |
| RIP bushings facility | Backward integration step three | Q4 FY27 |
| Fabrication facility | Backward integration step four | Q1 FY28 |
| Backward integration margin benefit | 200-300 bps, gradual from FY28 | Starting FY28 |
| HVDC manufacturing readiness | PGCIL empanelment for first trial order to follow | 15-16 months |
| Revenue target | INR8,000 crores | FY29 |
| FY28 guidance | Clear guideline to be provided | Q4 FY27 |
| Working capital days | 120 to 130 days on average | Ongoing |
| Inventory reduction | Gradual reduction starting | Q4 FY28 |
| Moraiya utilization | 80-85% target | Going forward |
Key Metrics
| Metric | Q1 FY27 |
|---|---|
| Standalone revenue | ₹559 cr, +10% YoY |
| Consolidated revenue | ₹572 cr |
| Standalone EBITDA | ₹87 cr, margin 15.6% |
| Consolidated EBITDA | ₹110 cr, margin 19.2% |
| Standalone PAT | ₹50 cr, margin 8.9% |
| Consolidated PAT | ₹64 cr |
| FY27 revenue growth guidance | 25% |
| FY27 standalone EBITDA margin guidance | 16% (includes other income) |
| FY27 consolidated EBITDA margin guidance | 20% to 21% or beyond |
| FY27 PAT margin guidance | 9% to 10% |
| Unexecuted order book | ₹6,630 cr, +26% YoY |
| Order inflow | ₹2,114 cr, +218% YoY |
| Inquiries under negotiation | ₹23,000 cr, win ratio historically 10% to 15% |
| Standalone debt-to-equity | 0.3x, debt ₹424 cr vs net worth ₹1,410 cr (FY26) |
| Standalone debt-to-EBITDA | 1.1x (FY26) |
| Net working capital days | ~170 days, inventory ~85 days, receivables 130 days (FY26) |
| Standalone ROCE | 19.1% in FY26, improved from 11.1% in FY21 |
| Standalone ROE | 15.7% in FY26, improved from 2.1% in FY21 |
| 5-year standalone revenue CAGR | 27% |
| 5-year standalone PAT CAGR | 101% |
| Changodar capacity utilization | 27% in Q1, impacted by ongoing expansion; expected 60%–65% in FY27, 80%–85% from FY28 |
| Moraiya capacity utilization | 57% in Q1, expected to reach 80%–85% |
| Backward integration margin benefit | 200–300 bps expected from FY28 onward |
| Export revenue share | 10% to 15%, will not exceed 15% |
| Revenue target by FY29 | ~₹8,000 cr (revised from earlier $1 bn target) |